Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 422
Selected: 0
NCT IDTitle
NCT00002763High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
NCT00002549Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
NCT01802814International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010
NCT02214134SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
NCT00042887Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer
NCT00062231Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
NCT05947903Validation of the European Oncology Quality of Life Toolkit
NCT01189253Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
NCT03235245Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib
NCT05512364Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT00017277Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer
NCT04031872LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
NCT00091234Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
NCT04995575Dissecting the Pathways of Therapy Resistance in Early Breast Cancer
NCT00041236Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00410462Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
NCT00003941Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer
NCT00027677Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
NCT00025636Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
NCT00003984Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
NCT00685828Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
NCT00010153ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
NCT02051868International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel
NCT03470350Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer
NCT00002669Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00006354Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
NCT02355353Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer
NCT00085475Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
NCT00091156Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00085059Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma
NCT00002701Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
NCT00003031Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
NCT01838577Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study
NCT00066339Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy
NCT00002764Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
NCT00020839Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain
NCT03101475Synergism of Immunomodulation and Tumor Ablation
NCT00085228Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
NCT00085163Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
NCT01208064Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy
NCT00689221Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status
NCT01386398Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma
NCT00433589Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
NCT02394626Surgery for Recurrent Glioblastoma
NCT00003989ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma
NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
NCT01724333International Validation of the QLQ-OH17 for Oral Health
NCT00006230Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
NCT03088059Biomarker-based Study in R/M SCCHN
NCT00005061Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors